Making Hope Tangible: How Terumo Blood And Cell Technologies' Are Advancing Cell and Gene Therapies
Terumo Blood and Cell Technologies, part of the Terumo Group, is focused on harnessing the power of blood and cells. The company is delivering expertise in automating cell therapy manufacturing to help reduce manual steps and bring speed, efficiency and scalability to the commercialization of therapies. The company firmly believes in the ground-breaking effect of cell and gene therapies, that cell therapies have the potential to go to the root cause and actually cure the diseases and that's what makes them powerful. Learn more about the to development of patient-centric innovations to help revolutionize health care and improve clinical outcomes.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.